MedPath

The Effects of Inhalation of Rosa Damascene Essential Oil on Fatigue and Anxiety among Cancer Patients Receiving Chemotherapy

Not Applicable
Conditions
People with cancer under chemotherapy.
Malignant neoplasm, unspecified
Registration Number
IRCT20111015007803N3
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

Age greater than 18 and less than 70 years
Cancer patients with at least one chemotherapy course with a 21 day interval from the last session.
Detect stage 2, 3, and 4 of all cancers other than head and neck and lung with the opinion of the relevant physician.
Full vigilance
No history of cigarette and drug addiction
Earning a score higher than 20 after responding to the Spielberger questionnaire in the pre-test
Non-use of benzodiazepines, tranquillizers and opioids during intervention
Without a history of migraine and chronic headaches
Non-impaired sense of smell (without obstruction and nasal congestion) and healthy sense of smell) through smelling of alcohol).
Inability of the patient to answer questions (in terms of physical and mental status)
lack of patient psychiatric problems (hospitalization or other medical treatment is not due to mental disorders).
Stable and stable hemodynamic status
Not having a history of allergy to the smell of herbs and any scent or fragrance
Not having respiratory diseases
The desire to participate in research
Do not use any other scent during the study

Exclusion Criteria

Patients with head and neck cancer

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatigue of patients with cancer under chemotherapy. Timepoint: Before the intervention and 30, 60 minutes after the intervention for three consecutive days. Method of measurement: Standard Fatigue Fatigue Questionnaire (BFI).;Anxiety in patients with cancer under chemotherapy. Timepoint: Before the intervention and 20 minutes after the intervention for three consecutive days. Method of measurement: Spilberger Situational Anxiety Inventory.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath